title: A prescribed Chinese herbal medicine improves glucose profile and ameliorates oxidative stress in Goto-Kakisaki rats fed with high fat diet.
abstract: Oxidative stress (OS) plays a role in hyperglycemia induced islet β cell dysfunction, however, studies on classic anti-oxidants didn't show positive results in treating diabetes. We previously demonstrated that the prescribed Chinese herbal medicine preparation "Qing Huo Yi Hao" (QHYH) improved endothelial function in type 2 diabetic patients. QHYH protected endothelial cells from high glucose-induced damages by scavenging superoxide anion and reducing production of reactive oxygen species. Its active component protected C2C12 myotubes against palmitate-induced oxidative damage and mitochondrial dysfunction. In the present study, we investigated whether QHYH protected islet β cell function exacerbated by high fat diet (HFD) in hyperglycemic GK rats. 4-week-old male rats were randomly divided into high HFD feeding group (n = 20) and chow diet feeding group (n = 10). Each gram of HFD contained 4.8 kcal of energy, 52% of which from fat. Rats on HFD were further divided into 2 groups given either QHYH (3 ml/Kg/d) or saline through gastric tube. After intervention, serum glucose concentrations were monitored; IPGTTs were performed without anesthesia on 5 fasting rats randomly chosen from each group on week 4 and 16. Serum malondialdehyde (MDA) concentrations and activities of serum antioxidant enzymes were measured on week 4 and 16. Islet β cell mass and OS marker staining was done by immunohistochemistry on week 16. QHYH prevented the exacerbation of hyperglycemia in HFD feeding GK rats for 12 weeks. On week 16, it improved the exacerbated glucose tolerance and prevented the further loss of islet β cell mass induced by HFD. QHYH markedly decreased serum MDA concentration, increased serum catalase (CAT) and SOD activities on week 4. However, no differences of serum glucose concentration or OS were observed on week 16. We concluded that QHYH decreased hyperglycemia exacerbated by HFD in GK rats by improving β cell function partly via its antioxidant effect.
authors.affiliation: Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Wu
authors.forename: Xiang
authors.initials: X
authors.lastname: Li
authors.forename: Hongguang
authors.initials: H
authors.lastname: Zhu
authors.forename: Ping
authors.initials: P
authors.lastname: Xu
authors.forename: Xin
authors.initials: X
authors.lastname: Gao
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D059305:Diet, High-Fat; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006943:Hyperglycemia / Q000188:drug therapy / Q000378:metabolism; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D018384:Oxidative Stress / Q000187:drug effects*; D051381:Rats; D013997:Time Factors
chemical_list: D000975:Antioxidants; D001786:Blood Glucose; D004365:Drugs, Chinese Herbal; D005947:Glucose
references.citation: Eur J Clin Invest. 2012 Dec;42(12):1287-94
references.pmid: 23033884
references.citation: Isr Med Assoc J. 2009 Oct;11(10):598-601
references.pmid: 20077945
references.citation: Pancreas. 2007 Apr;34(3):347-53
references.pmid: 17414058
references.citation: Pharmaceuticals (Basel). 2010 Mar 22;3(3):764-781
references.pmid: 27713278
references.citation: Diabetes Res Clin Pract. 2011 May;92(2):253-60
references.pmid: 21371770
references.citation: Diabetes. 2002 Mar;51(3):662-8
references.pmid: 11872664
references.citation: Pancreas. 2002 Nov;25(4):393-9
references.pmid: 12409835
references.citation: Life Sci. 2011 Apr 25;88(17-18):803-9
references.pmid: 21396380
references.citation: Arch Biochem Biophys. 2009 Apr 15;484(2):221-31
references.pmid: 19402213
references.citation: Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E17-27
references.pmid: 19843875
references.citation: Pflugers Arch. 2010 Sep;460(4):703-18
references.pmid: 20652307
references.citation: Diabetes Res Clin Pract. 2006 Feb;71(2):140-5
references.pmid: 15990193
references.citation: Br J Pharmacol. 2008 Mar;153(5):894-906
references.pmid: 17906683
references.citation: Mol Cell Endocrinol. 2009 Jan 15;297(1-2):73-85
references.pmid: 18640239
references.citation: Diabetol Metab Syndr. 2009 Oct 16;1(1):17
references.pmid: 19835614
references.citation: Eur J Endocrinol. 2010 Mar;162(3):535-41
references.pmid: 20022940
references.citation: Diabetologia. 2011 Sep;54(9):2337-46
references.pmid: 21547497
references.citation: Life Sci. 2009 Mar 27;84(13-14):428-36
references.pmid: 19302821
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):9-15
references.pmid: 15936182
references.citation: Braz J Med Biol Res. 2007 Aug;40(8):1095-9
references.pmid: 17665046
references.citation: J Physiol Biochem. 2011 Dec;67(4):613-9
references.pmid: 21698418
references.citation: N Engl J Med. 2006 Dec 7;355(23):2427-43
references.pmid: 17145742
references.citation: Clinics (Sao Paulo). 2012 Dec;67(12):1469-77
references.pmid: 23295603
references.citation: Cell Biochem Biophys. 2007;48(2-3):139-46
references.pmid: 17709883
references.citation: Diabetes Care. 2009 Nov;32 Suppl 2:S232-6
references.pmid: 19875557
references.citation: Islets. 2010 Mar-Apr;2(2):104-11
references.pmid: 21099302
references.citation: Aliment Pharmacol Ther. 2008 Sep 15;28(6):689-703
references.pmid: 19145725
references.citation: Diabetes Care. 2007 Mar;30(3):649-54
references.pmid: 17327335
references.citation: Toxicol Lett. 2011 Feb 25;201(1):15-26
references.pmid: 21145380
references.citation: J Clin Endocrinol Metab. 2011 Aug;96(8):2354-66
references.pmid: 21697254
references.citation: Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):434-9
references.pmid: 12615693
references.citation: Physiol Res. 2009;58(2):203-209
references.pmid: 18380531
references.citation: J Endocrinol. 2010 Jul;206(1):47-54
references.pmid: 20453078
references.citation: Int J Biochem Cell Biol. 2009 Jul;41(7):1526-35
references.pmid: 19166964
references.citation: Ann Intern Med. 2005 Jan 4;142(1):37-46
references.pmid: 15537682
references.citation: PLoS One. 2009 Aug 05;4(8):e6500
references.pmid: 19654863
references.citation: Acta Pharmacol Sin. 2012 Apr;33(4):496-502
references.pmid: 22426699